关注
Ugbaja Samuel Chima
Ugbaja Samuel Chima
其他姓名Ugbaja C. Samuel
School of Laboratory Medicine and Medical Sciences, University of KwaZulu Natal South Africa
在 ukzn.ac.za 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer‐Aided Drug Discovery Approaches over the Past Five Years
AM Magwenyane, SC Ugbaja, DG Amoako, AM Somboro, RB Khan, ...
Computational and mathematical methods in medicine 2022 (1), 2147763, 2022
192022
Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment
SC Ugbaja, ZK Sanusi, P Appiah-Kubi, MM Lawal, HM Kumalo
Biophysical Chemistry 270, 106536, 2021
172021
Alzheimer's disease and β-secretase inhibition: an update with a focus on computer-aided inhibitor design
SC Ugbaja, IA Lawal, HM Kumalo, MM Lawal
Current drug targets 23 (3), 266-285, 2022
132022
Unravelling the molecular basis of AM-6494 high potency at BACE1 in Alzheimer’s disease: An integrated dynamic interaction investigation
SC Ugbaja, P Appiah-Kubi, MM Lawal, NS Gumede, HM Kumalo
Journal of Biomolecular Structure and Dynamics 40 (12), 5253-5265, 2022
112022
Allostery inhibition of BACE1 by psychotic and meroterpenoid drugs in Alzheimer’s disease therapy
SC Ugbaja, IA Lawal, BH Abubakar, AG Mushebenge, MM Lawal, ...
Molecules 27 (14), 4372, 2022
82022
An Overview of β-Amyloid Cleaving Enzyme 1 (BACE1) in Alzheimer's Disease Therapy: Elucidating its Exosite-Binding Antibody and Allosteric Inhibitor
SC Ugbaja, MM Lawal, HM Kumalo
Current Medicinal Chemistry 29 (1), 114-135, 2022
72022
Structural investigations and binding mechanisms of oseltamivir drug resistance conferred by the E119V mutation in influenza H7N9 virus
SC Ugbaja, SE Mtambo, AG Mushebenge, P Appiah-Kubi, BH Abubakar, ...
Molecules 27 (14), 4376, 2022
52022
GC–MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts’ compounds for analgesic and anti-inflammatory activities in dentistry
I Chikowe, KD Bwaila, SC Ugbaja, AS Abouzied
Scientific Reports 14 (1), 1876, 2024
32024
Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation
AG Mushebenge, SC Ugbaja, SE Mtambo, T Ntombela, JI Metu, ...
Molecules 28 (6), 2641, 2023
32023
Assessing the potential contribution of in silico studies in discovering drug candidates that interact with various SARS-CoV-2 receptors
AGA Mushebenge, SC Ugbaja, NA Mbatha, R B. Khan, HM Kumalo
International Journal of Molecular Sciences 24 (21), 15518, 2023
22023
A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations
AGA Mushebenge, SC Ugbaja, NA Mbatha, RB Khan, HM Kumalo
COVID 3 (9), 1454-1472, 2023
22023
An updated research focus on the employment of computer-aided drug discovery and repurposing techniques for the identification and evaluation of SARS-CoV-2 Main protease …
AGA Mushebenge, SC Ugbaja, NA Mbatha, MG Riziki, TW Muzumbukilwa, ...
medRxiv, 2023.07. 28.23293282, 2023
12023
Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex
SE Mtambo, SC Ugbaja, AG Mushebenge, BH Abubakar, ML Ntuli, ...
Molecules 27 (5), 1640, 2022
12022
Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective
SE Mtambo, SC Ugbaja, HM Kumalo
Molecules 27 (5), 1645, 2022
12022
A Triangulation of Information from Healthcare Workers and Patients about the Concurrent Use of Traditional Medicine and Conventional Prescribed Medicines for Schistosomiasis …
AGA Mushebenge, SC Ugbaja, NA Mbatha, MG Riziki, TW Muzumbukilwa, ...
Preprints, 2024
2024
Knowledge, Perceptions, and Experiences of Traditional Health Practitioners about Managing Female Urogenital Schistosomiasis: The Case of ILembe District, KwaZulu-Natal …
AGA Mushebenge, SC Ugbaja, NA Mbatha, MG Riziki, TW Muzumbukilwa, ...
Preprints, 2024
2024
Unravelling Insights into the Evolution and Management of SARS-CoV-2
AGA Mushebenge, SC Ugbaja, NA Mbatha, RB Khan, HM Kumalo
BioMedInformatics 4 (1), 385-409, 2024
2024
Mechanistic Insights into Targeting SARS-CoV-2 Papain-Like Protease in the Evolution and Management of COVID-19: A Comprehensive Review
NN MAGWAZA, A MUSHEBENGE, SC UGBAJA, NA MBATHA, RB KHAN, ...
Preprints, 2023
2023
A Molecular Modeling and Molecular Dynamics Simulations Investigation of the Potential Therapeutic Applications of Main Protease Inhibitors for SARS-CoV-2
AGA Mushebenge, SC Ugbaja, NA Mbatha, RM Khan, HM Kumalo
Preprints, 2023
2023
Unravelling Insights into the Evolution and Management of SARS-CoV-2: A Comprehensive Review
A Mushebenge, SC Ugbaja, NA Mbatha, RM Khan, HM Kumalo
Preprints, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20